Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Brazil grants special 24-month spinosad approval

Brazil granted a 24-month emergency authorisation for use of the insecticide, spinosad, on three crops late last year. The Ministry of Agriculture approved spinosad-based products as foliar applications for the control of fruit flies ( Ceratitis capitata and Anastrepha spp) on guavas, grapevines, acerolas and mangoes. Products are to be applied only at 1-1.6 litres/ha. Interested companies seeking to market products must obtain registrations from the competent authorities. Applications are to be accompanied by draft labels and literature along with proof of authorisations in individual states, the federal district and the Ministry’s pesticide co-ordination office. Registrations will include a commitment to the production and submitting of studies, while they would be cancelled if agronomic, toxicological or efficacy concerns were subsequently found. The Ministry’s agricultural research corporation, the Embrapa, identified emergency measure requirements including “cultural control” and monitoring, following a study in the San Francisco valley area.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts